Belzutifan plus cabozantinib combination shows promise in advanced kidney cancer
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
Combinations of tyrosine kinase inhibitors plus immunotherapy have improved treatment [...]
Just after Christmas, the US Food and Drug Administration (FDA) [...]
The first results from a phase 2 study (FRACTION-RCC) looking [...]
A new treatment, called NDI-101150 has been shown to be [...]
This article gives some good advice about how to manage [...]
The US Food and Drug Administration (FDA) has granted a [...]
We are delighted to announce that the National Institute for [...]
The Francis Crick Institute and The Royal Marsden NHS Foundation [...]
This year’s European Society for Medical Oncology (ESMO) Congress was [...]